Si Sun
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
Papers in ⓘ
- Oncology 56
- Lung Cancer Research Studies 13
- HER2/EGFR in Cancer Research 10
- Cancer Immunotherapy and Biomarkers 9
- Colorectal Cancer Treatments and Studies 9
-
- Cancer-related molecular mechanisms research 10
- Co-authors
- Qi Wu (25 shared papers)Shengrong Sun (23 shared papers)Juanjuan Li (8 shared papers)Yang Ouyang (2 shared papers)Jing Cai (26 shared papers)Xiaoyu Fu (2 shared papers)Zehua Wang (19 shared papers)Xinyue Chen (1 shared paper)
- Journals
- Frontiers in Oncology (7 papers)Frontiers in Immunology (5 papers)Oncotarget (5 papers)BMC Cancer (4 papers)Journal of Cancer Research and Clinical Oncology (4 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Si Sun
138 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Cancer Research 737
- Oncology 857
- Molecular Biology 1.4k
- Pulmonary and Respiratory Medicine 565
- Immunology 319
Countries citing papers authored by Si Sun
This map shows the geographic impact of Si Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Si Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Si Sun more than expected).
Fields of papers citing papers by Si Sun
This network shows the impact of papers produced by Si Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Si Sun. The network helps show where Si Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Si Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 147 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chalcone Derivatives: Role in Anticancer Therapy Hit paper breakdown → | 2021 | 259 |
| 2 | 2014 | 218 | |
| 3 | 2015 | 139 | |
| 4 | 2011 | 109 | |
| 5 | 2020 | 103 | |
| 6 | 2022 | 101 | |
| 7 | 2019 | 88 | |
| 8 | 2021 | 73 | |
| 9 | 2017 | 70 | |
| 10 | 2020 | 69 | |
| 11 | 2020 | 51 | |
| 12 | 2018 | 47 | |
| 13 | 2021 | 45 | |
| 14 | 2021 | 43 | |
| 15 | 2016 | 41 | |
| 16 | 2023 | 37 | |
| 17 | 2018 | 37 | |
| 18 | 2022 | 37 | |
| 19 | 2016 | 36 | |
| 20 | 2016 | 36 |
About Si Sun
Si Sun is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Obstetrics and Gynecology and Reproductive Medicine, having authored 147 papers that have together received 2.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (21 papers), Epigenetics and DNA Methylation (13 papers), Lung Cancer Research Studies (13 papers), HER2/EGFR in Cancer Research (10 papers), Cancer-related molecular mechanisms research (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Ovarian cancer diagnosis and treatment (9 papers) and Colorectal Cancer Treatments and Studies (9 papers). The work is most often cited by research in Cancer Research (737 citations), Oncology (857 citations), Molecular Biology (1.4k citations), Pulmonary and Respiratory Medicine (565 citations) and Immunology (319 citations). Si Sun has collaborated with scholars based in China, United States and France. Frequent co-authors include Qi Wu, Shengrong Sun, Juanjuan Li, Yang Ouyang, Jing Cai, Xiaoyu Fu, Zehua Wang, Xinyue Chen, Juanjuan Li and Jian Zhang. Their work appears in journals such as Frontiers in Oncology, Frontiers in Immunology, Oncotarget, BMC Cancer and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.